- \n
- Vetter\u2019s high-level performance further substantiates its dedicated performance in customer-critical services <\/li>\n
- Results affirm the approach, vision, and strategy of the company\u2019s daily work for customers <\/li>\n
- High ranking is further affirmation of customer experiences in working with Vetter as a strong and reliable partner <\/li>\n<\/ul>\n
<\/b> RAVENSBURG, GERMANY – Media OutReach<\/a> – 3 March 2022 – Vetter<\/a>, a globally operating Contract Development and Manufacturing Organization (CDMO), won the 2022 CMO Leadership Awards <\/a> in all six core categories \u2013 quality<\/i>, expertise<\/i>, compatibility<\/i>, capabilities<\/i>, reliability <\/i>and service<\/i>. Vetter also achieved Champion status in the areas of quality<\/i>, expertise<\/i> and compatibility<\/i>. The award, now in its eleventh year, was given by the leading trade press publication, Life Science Leader<\/a>. Due to the ongoing Covid-19 pandemic, the awards ceremony will be held virtually beginning of March. <\/p>\n\n![\"\u00a9](\"https:\/\/release.media-outreach.com\/release.php\/Images\/225305\/Vetters-1.jpg\")
\n <\/p>\n\u00a9 Vetter Pharma International GmbH: <\/b>As a competent and reliable partner, Vetter makes an essential contribution to the supply of patients with vital drugs.<\/i><\/div>\n<\/i> <\/div>\n<\/figcaption><\/figure>\n<\/div>\n
![\"\u00a9](\"https:\/\/release.media-outreach.com\/release.php\/Images\/225312\/CMO-2.jpg\")
\n <\/p>\n\u00a9 Vetter Pharma International GmbH: <\/b>Winning the CMO Leadership Awards 2022 in all six categories along with Champion status in three is an unprecedented achievement for Vetter.<\/i><\/div>\n<\/i> <\/div>\n<\/figcaption><\/figure>\n
\u201cOur result this year is an unprecedented achievement for Vetter and represents a landmark victory for the company,\u201d said Vetter Managing Director Peter Soelkner. \u201cTo win in all six categories is exceptional in its own right. However, to be awarded Champion in the areas of Compatibility,<\/i> Quality and Expertise<\/i> is particularly rewarding and reflects the day-to-day dedication and hard work of our 5,700 employees on three continents.\u201d C arsten Press, Vetter\u2019s Senior Vice President Key Account Management\/Supply Chain Management\/Marketing added, \u201cWithout doubt, this achievement firmly demonstrates that we continuously strive to meet or even exceed our global customers\u2019 expectations. The awards mirror our partnership approach to be a trusted source for producing life-critical medications for patients in need.\u201d <\/p>\n
The CMO Leadership Awards program is unique among other industry awards since winners are chosen according to customer evaluations of the service providers they have actually worked with in the past 18 months. Thus, results cannot be influenced in any manner and are truly representative of actual customer performance. <\/p>\n
\u201cFor nearly a decade, these awards have proven most meaningful for biopharma organizations striving to obtain optimal outcomes from their outsourcing activities. Our research arm, Industry Standard Research <\/a> (ISR), which only surveys drug sponsors who have worked recently with specific CDMOs, ensures the validity of these results. Our winners will be your champions of outsourcing,\u201d said Louis Garguilo, Chief Editor and Conference Chair, Outsourced Pharma. <\/p>\n
In this short video<\/b><\/a>, Carsten Press offers his insight on how winning the awards has a positive impact on Vetter\u2019s future cooperation with customers.<\/b> <\/p>\n
Find the Vetter press kit and more background information <\/b><\/span>here<\/b><\/a>.<\/b><\/span><\/b> <\/p>\n
About the CMO Leadership Awards<\/h4>\n
The CMO Leadership Awards is an annual event now in its eleventh year. In determining the award recipients, <\/span>
![](\"https:\/\/release.media-outreach.com\/Release\/templates\/images\/socialMedia\/generic_link.png\")
Life Science Leader<\/a><\/span> <\/i>teams up with (<\/span>ISR<\/a><\/span>) which conducted the research. For the 2022 award, more than 86 contract manufacturers were assessed by 23 performance metrics in ISR\u2019s annual Contract Manufacturing Quality Benchmarking<\/i> survey. Participants were recruited from pharma and biotech companies of all sizes and screened for decision-making influence related to working with contract manufacturing partners. Respondents only evaluate those companies with which they have worked on an outsourced project within the past 18 months. Through this level of qualification, survey responses are based on actual involvement with contract manufacturers and clear experiential data.<\/span> <\/p>\n<\/p>\nAbout Vetter<\/h4>\n<\/p>\n
Headquartered in Ravensburg, Germany, Vetter is a family-owned, global leading contract development and manufacturing organization (CDMO) with production facilities in Germany, Austria and the United States. Currently employing more than <\/span><\/span>
5,700 individuals worldwide<\/span><\/a><\/span>, the company has long-term experience in supporting biotechnology and pharmaceutical customers both large and small. Vetter <\/span>services<\/span><\/a><\/span> range from early stage development support including <\/span>clinical manufacturing<\/span><\/a><\/span>, to <\/span>commercial supply<\/span><\/a><\/span> and <\/span>numerous packaging solutions<\/span><\/a><\/span> for vials, syringes and cartridges. As a leading solution provider, Vetter appreciates its responsibility to support the needs of its customers by developing devices that contribute to increased patient safety, convenience, and enhanced compliance. Great importance is also given to <\/span>social responsibility<\/span><\/a><\/span>,<\/span><\/u> <\/span>including environmental protection and sustainability. Learn more about Vetter at <\/span>www.vetter-pharma.com<\/span><\/a><\/span>. <\/p>\n#Vetter<\/span> <\/p>\n